Coronavirus: Alarm at German AstraZeneca pause as instances spike


Emer Cooke, government director of the European Medicines Company, stated the EMA was nonetheless “firmly satisfied” of the advantages of the AstraZeneca drug, and she or he identified that blood clots highlighted by some nations had been comparatively frequent within the normal inhabitants. The primary query was whether or not it was an actual side-effect of the vaccine or a coincidence, she stated.